Vivos Therapeutics (VVOS) Cash from Operations (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Cash from Operations of 6000000.0 for Q1 2026, down 57.89% year-over-year from 14250000.0 in Q1 2025, and down 59.45% quarter-over-quarter from 3763000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Cash from Operations (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Cash from Operations for 7 consecutive years, with 6000000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 57.89% year-over-year to 6000000.0; the TTM figure through Mar 2026 stood at 17463000.0 (down 24.88% YoY), while the FY2025 annual figure was 15263000.0, down 20.18% from the prior year.
- Cash from Operations slipped to 6000000.0 in Q1 2026 per VVOS's latest filing, from 3763000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2516000.0 in Q1 2024 and bottomed at 6082000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 3850764.71 across 5 years, with a median of 3539000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 52.07% — and 2026, when it slumped 57.89%.
- Vivos Therapeutics' Cash from Operations stood at 3013000.0 in 2022, then advanced by 10.32% to 2702000.0 in 2023, then fell by 9.14% to 2949000.0 in 2024, then retreated by 27.6% to 3763000.0 in 2025, then tumbled by 59.45% to 6000000.0 in 2026.
- Business Quant data shows VVOS's Cash from Operations at 6000000.0 in Q1 2026, 3763000.0 in Q4 2025, and 4200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Vivos Therapeutics | 4.93 Mn | 3.13 Mn | 2.95 Mn | -3.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.00 Mn |
| Mar 31, 2026 | -6.00 Mn |
| Dec 31, 2025 | -3.76 Mn |
| Dec 31, 2025 | -3.76 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |